WE ARE
A pharmaceutical company specialized in high quality
ONCOLOGY PRODUCTS
We are a pharmaceutical company specialized in high-quality oncology products in the Middle East. Actero is the result of the joint venture between Actoverco (the Iranian leading pharmaceutical company) and a renowned multinational company currently present in 120 countries.
We are building a unique range of products to cover the needs of cancer patients. Actero is not only focused on chemotherapy, but understands cancer treatment as a whole. That is why we invest in high-quality oncology drugs, as well as in palliative care. All across our portfolio, every Actero medicine stands for reliability.
November 17, 2024
The 23rd National Congress of the Iranian Society of Medical Oncology supported by Actero
The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital, Tehran, alongside many experienced professors and colleagues from the Blood and Oncology Department.
/
September 25, 2024
The 6th International Congress of Uro-Oncology supported by Actero
The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital
/
August 28, 2024
Nahaleh Naraqi honors National Doctors Day in Iran
Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.
/
Find Your Product
With our products, we contribute to the health of people and plants. Here you find an overview of the major Acteropharma products.
A
Z
We understand that pharmaceutical industry is not comparable to other industries. That is why ethical behavior is at the heart of our business.